To study effectiveness and safety and of regorafenib in recurrent hepatocellular carcinoma after progression on sorafenib and liver transplantation
Latest Information Update: 13 Sep 2019
At a glance
- Drugs Regorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 13 Sep 2019 New trial record